Chemical Abstracts Service announced 5-year agreement for SciFinder®, the choice for chemistry research, with AstraZeneca, a leading biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. Long-term agreement guarantees AstraZeneca researchers access to the most accurate, comprehensive, and current research, and signifies the confidence customers have in CAS as a high-quality information partner.
This story is related to the following:Trade Associations